| Natural Capsules Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 524654 |
NSE Symbol : NATCAPSUQ |
P/E(TTM) : 17.45 |
|
ISIN Demat : INE936B01015 |
Div & Yield% : 0.00 |
EPS(TTM) : 9.34 |
|
Book Value(₹) : 166.77 |
Market Cap(₹Cr) : 168.56 |
Face Value(₹) : 10.00 |
| Particulars | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 44.58 | 44.24 | 44.36 | 43.41 | 41.03 | 39.14 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 44.58 | 44.24 | 44.36 | 43.41 | 41.03 | 39.14 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 1.73 | 1.69 | 1.55 | 1.15 | 0.77 | 0.76 |
| Total Income | 46.31 | 45.93 | 45.91 | 44.56 | 41.80 | 39.90 |
| Total Expenditure | 39.14 | 39.11 | 39.31 | 38.83 | 36.09 | 34.42 |
| PBIDT | 7.17 | 6.83 | 6.60 | 5.74 | 5.71 | 5.49 |
| Interest | 1.45 | 1.36 | 1.52 | 1.39 | 1.54 | 1.46 |
| PBDT | 5.72 | 5.47 | 5.07 | 4.35 | 4.17 | 4.03 |
| Depreciation | 2.02 | 1.99 | 1.94 | 2.14 | 2.16 | 2.09 |
| Tax | 0.88 | 0.88 | -0.27 | 0.42 | 0.61 | 0.46 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.01 | 0.07 | 0.78 | 0.09 | 0.48 | 0.02 |
| Reported Profit After Tax | 2.81 | 2.52 | 2.63 | 1.70 | 0.92 | 1.46 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 2.81 | 2.52 | 2.63 | 1.70 | 0.92 | 1.46 |
| EPS (Unit Curr.) | 2.72 | 2.44 | 2.17 | 1.65 | 0.90 | 1.56 |
| EPS (Adj) (Unit Curr.) | 2.72 | 2.44 | 2.17 | 1.65 | 0.90 | 1.56 |
| Calculated EPS (Unit Curr.) | 2.72 | 2.44 | 2.54 | 1.65 | 0.90 | 1.56 |
| Calculated EPS (Adj) (Unit Curr.) | 2.72 | 2.44 | 2.54 | 1.65 | 0.90 | 1.56 |
| Calculated EPS (Ann.) (Unit Curr.) | 10.87 | 9.76 | 10.16 | 6.59 | 3.60 | 6.25 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 10.87 | 9.76 | 10.16 | 6.59 | 3.60 | 6.25 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 10.34 | 10.34 | 10.34 | 10.34 | 10.25 | 9.34 |
| Reserve & Surplus | 162.12 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 16.08 | 15.44 | 14.88 | 13.22 | 13.92 | 14.03 |
| PBDTM(%) | 12.83 | 12.36 | 11.43 | 10.02 | 10.16 | 10.30 |
| PATM(%) | 6.30 | 5.70 | 5.93 | 3.92 | 2.24 | 3.73 |